Abstract
VIRAL material used to prepare inactivated virus vaccines must be concentrated to provide sufficient antigenic mass to stimulate the vaccine's protective mechanisms, and purified to remove nonviral host material which may cause side reactions and sensitization to host (for example, egg) components. A continuous-flow zonal centrifuge, the K-II-B1,2, has been designed for use in large scale production of influenza vaccines. We have grown influenza virus in tissue culture and have concentrated and purified it in a single step process using this centrifuge.
Similar content being viewed by others
References
Anderson, N. G., Quart. Rev. Biophys., 1, 217 (1968).
Waters, D., Gibson, R., and Babelay, E., Fed. Proc., 27, 365 (1968).
Peck, F. B., Fed. Proc., 27, 365 (1968).
Howe, C., Lee, L., Harboe, A., and Haukenes, G., J. Immunol., 98, 543 (1967).
Laver, W., and Webster, R., Virology, 30, 104 (1966).
Weiss, R., and Schleicher, J., Amer. Chem. Soc. Abst., Q049, 154th Meeting, Chicago, Illinois, Sept. 10–15, 1967.
Reimer, C., Baker, R., van Frank, M., Newlin, T., Cline, G., and Anderson, N. G., J. Virol., 1, 1207 (1967).
Gerin, J., Fricke, H., Marquis, G., and Holper, J., Fed. Proc., 27, 365 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
GERIN, J., ANDERSON, N. Purification of Influenza Virus in the K-II Zonal Centrifuge. Nature 221, 1255–1256 (1969). https://doi.org/10.1038/2211255a0
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1038/2211255a0
- Springer Nature Limited